Stocksigma LogoStocksigma Logo

Eris Lifesciences Appoints Akhil Awasthi as Independent Director for Five-Year Term

Eris Lifesciences approved the appointment of Mr. Akhil Awasthi as an Additional Director (Non-Executive, Independent) for a five-year term, effective 26th

Eris Lifesciences Appoints Akhil Awasthi as Independent Director for Five-Year Term

Eris Lifesciences Ltd 路 Others (Uncategorized) 路 21 Sept 2026, 2:41 pm

Eris Lifesciences Appoints Akhil Awasthi as Independent Director for Five-Year Term Eris Lifesciences approved the appointment of Mr. Akhil Awasthi as an Additional Director (Non-Executive, Independent) for a five-year term, effective 26th Sep'26, subject to shareholder approval. Mr. Awasthi brings over 30 years of experience across private equity, healthcare, lifesciences, and corporate governance. His background includes leadership roles as Founding Managing Partner at Tata Capital Growth Fund and Partner at Baring Private Equity Partners (India). He holds no familial ties to existing directors and faces no regulatory debarment from holding board positions.

Original exchange filing (PDF)

More announcements from Eris Lifesciences Ltd

All Eris Lifesciences Ltd announcements